Evidence map›Paper›PMID 41262560›Full record

ArticleACS pharmacology & translational science2025

Cannabidiol in Sports: A Brazilian Perspective.

Tatyana Nery, Jose Wilson Nv Andrade, Jimmy Fardin Rocha, Ana Paula Pinto de Araújo, Aderbal Silva Aguiar

Abstract read
In one paragraph

Article in ACS pharmacology & translational science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Tatyana NeryLABIOEX-Laboratory of Exercise Biology, Federal University of Santa Catarina-UFSC, Araranguá, Santa Catarina 88905-120, Brazil.ORCID https://orcid.org/0000-0002-7187-8756
Jose Wilson Nv AndradeInstitute for Education and Research (IEP) Remederi, São Paulo, São Paulo 04149-120, Brazil.ORCID https://orcid.org/0009-0007-5058-4082
Jimmy Fardin RochaInstitute for Education and Research (IEP) Remederi, São Paulo, São Paulo 04149-120, Brazil.ORCID https://orcid.org/0009-0005-6041-8219
Ana Paula Pinto de AraújoLABIOEX-Laboratory of Exercise Biology, Federal University of Santa Catarina-UFSC, Araranguá, Santa Catarina 88905-120, Brazil.ORCID https://orcid.org/0009-0009-0897-9456
Aderbal Silva AguiarLABIOEX-Laboratory of Exercise Biology, Federal University of Santa Catarina-UFSC, Araranguá, Santa Catarina 88905-120, Brazil.ORCID https://orcid.org/0000-0002-6825-3333

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This Viewpoint examines the emerging role of cannabidiol (CBD) in sports medicine, with a particular emphasis on its potential to support athlete health through indirect mechanisms. Rather than acting as a direct performance enhancer, CBD may contribute to improved readiness for training and competition by promoting better sleep, alleviating anxiety, and accelerating recovery. We also discuss challenges for antidoping compliance, including product contamination and regulatory gaps in Brazil, and highlight CBD's promise as a safer alternative to opioids for pain management in athletes.

Indexed as

antidopingcannabidiolrecoverysports medicine

Identifiers

PMID41262560
PMCPMC12624424

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.